11.07.2015 Views

Novel genetic and epigenetic alterations in ... - Ous-research.no

Novel genetic and epigenetic alterations in ... - Ous-research.no

Novel genetic and epigenetic alterations in ... - Ous-research.no

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Introductionexemplified by frequent mutations <strong>in</strong> specific regions of TP53 * , KRAS, BRAF <strong>and</strong> PIK3CA † .This can be expla<strong>in</strong>ed by selection pressure <strong>and</strong> clonal growth advantage[11]. If a mutationgives the cell a growth advantage it will have higher fitness compared to surround<strong>in</strong>g cells,lead<strong>in</strong>g to selection <strong>in</strong> accordance with the evolution theory[20]. On the same basis, , a cellwith a “<strong>no</strong>n-important” mutation, often de<strong>no</strong>ted passenger mutation, will <strong>no</strong>t have <strong>in</strong>creasedlikelihood of pass<strong>in</strong>g the acquired trait to its daughter cells. In the largest available mutationdatabase, Catalogue Of Somatic Mutations In Cancer (COSMIC), ~4800 of our 20-25000genes are <strong>in</strong>cluded[21], a number which also <strong>in</strong>cludes a large number of genes with <strong>no</strong>observed mutations. The number of genes which is essential for tumor formation is muchlower, <strong>and</strong> it has been estimated that just more than 1% of the human genes can beattributed “cancer critical” genes, as these are k<strong>no</strong>wn to be <strong>in</strong>volved <strong>in</strong> carc<strong>in</strong>ogenesis[22].DNA methylationMethylation is one of many possible chemical modifications of the double helix. At a CpGd<strong>in</strong>ucleotide, a cytos<strong>in</strong>e followed by a guan<strong>in</strong>e, a methyl group can covalently b<strong>in</strong>d to the5’position of cytos<strong>in</strong>e, constitut<strong>in</strong>g a 5-methylcytos<strong>in</strong>e, first described <strong>in</strong> 1948[23]. This willserve as a recognition mark for methyl b<strong>in</strong>d<strong>in</strong>g prote<strong>in</strong>s. The CpG d<strong>in</strong>ucleotide is greatlyunderrepresented <strong>in</strong> the human ge<strong>no</strong>me due to spontaneous deam<strong>in</strong>ation of 5-methylcytos<strong>in</strong>e throughout the evolution, caus<strong>in</strong>g a cytos<strong>in</strong>e to thym<strong>in</strong>e change that escapesthe DNA repair systems[24]. Hence, the rema<strong>in</strong><strong>in</strong>g CpG-sites are ma<strong>in</strong>ly located <strong>in</strong> areaswith a close to theoretically expected amount of CpG, called CpG-isl<strong>and</strong>s, but are alsopresent with<strong>in</strong> repetitive sequences. These isl<strong>and</strong>s are located <strong>in</strong> the 5’-ends of about half ofour genes <strong>and</strong> are under <strong>no</strong>rmal circumstances protected aga<strong>in</strong>st methylation[25].Both establishment <strong>and</strong> ma<strong>in</strong>tenance of methylation marks are governed by DNA methyltransferases (DNMTs). Dur<strong>in</strong>g DNA replication hemi-methylated DNA is recognized byDNMT1, <strong>and</strong> the methylation marks of the <strong>in</strong>itial str<strong>and</strong> are copied to the nascent DNAstr<strong>and</strong>, ensur<strong>in</strong>g a faithful <strong>in</strong>heritance of DNA methylation patterns <strong>in</strong> the daughter cells.This process is called ma<strong>in</strong>tenance methylation. DNMT3A <strong>and</strong> DNMT3B h<strong>and</strong>le the de <strong>no</strong>vo* IARC TP53 database – http://www-p53.iarc.fr/† Catalogue of Somatic Mutations <strong>in</strong> Cancer database – http://www.sanger.ac.uk/<strong>genetic</strong>s/CGP/cosmic/15

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!